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Exercise is essential in regulating energymetabolism
and whole-body insulin sensitivity. To explore the
exercise signaling network, we undertook a global
analysis of protein phosphorylation in human skeletal
muscle biopsies from untrained healthymales before
and after a single high-intensity exercise bout, re-
vealing 1,004 unique exercise-regulated phospho-
sites on 562 proteins. These included substrates of
known exercise-regulated kinases (AMPK, PKA,
CaMK, MAPK, mTOR), yet the majority of kinases
and substrate phosphosites have not previously
been implicated in exercise signaling. Given the
importance of AMPK in exercise-regulated meta-
bolism, we performed a targeted in vitro AMPK
screen and employedmachine learning to predict ex-
ercise-regulated AMPK substrates. We validated
eight predicted AMPK substrates, including AKAP1,
using targeted phosphoproteomics. Functional char-
acterization revealed an undescribed role for AMPK-
dependent phosphorylation of AKAP1 in mitochon-
drial respiration. These data expose the unexplored
complexity of acute exercise signaling and provide
insights into the role of AMPK in mitochondrial
biochemistry.
INTRODUCTION
Exercise plays an essential role in metabolic homeostasis and
remains themost promising therapy for the prevention and treat-
ment of obesity and its associated metabolic disorders. Physical
inactivity causes insulin resistance in humans, while increased
physical activity improves insulin sensitivity and whole body-922 Cell Metabolism 22, 922–935, November 3, 2015 ª2015 Elsevierglucose and lipid metabolism (Hawley et al., 2014). Exercise reg-
ulates diverse biological functions throughout the body with a
major perturbation of skeletal muscle cellular processes, in-
cluding fatty acid, glucose, and protein metabolism via induction
of a range of signal transduction pathways. Most studies of ex-
ercise signaling in muscle have focused on a limited subset of
pathways, particularly those involving protein phosphorylation.
The major protein kinases implicated in muscle exercise sig-
naling include AMPK, PKA, CaMK, MAPK, PKC, FAK, and
mTOR (Egan and Zierath, 2013; Jeppesen et al., 2013; Sakamoto
and Goodyear, 2002). The acute metabolic and mechanical de-
mands in exercising muscle require a coordinated regulation of
diverse signaling pathways that together form a complex sig-
naling network that elicits a range of rapid cellular homeostatic
adaptations. It is of major interest to define the key components
within this network that confer the long-term beneficial effects of
exercise.
The energy-sensing kinase AMPK (Hardie, 2014) plays an
important role in the beneficial effects of exercise on whole-
body metabolic homeostasis (Richter and Ruderman, 2009;
Steinberg and Kemp, 2009). Muscle-specific AMPK knockout
mouse models have demonstrated a crucial role for AMPK in
the metabolic adaptation of muscle during exercise (Fentz
et al., 2015; O’Neill et al., 2011). However, several reports have
suggested the previously characterized metabolic perturbations
induced with exercise are not dependent on AMPK (Jeppesen
et al., 2013; Maarbjerg et al., 2009). Despite this, the beneficial
effects of the antidiabetic drug metformin are at least partially
mediated via AMPK (Foretz et al., 2014; Fullerton et al., 2013;
Rena et al., 2013). Therefore, AMPK is a major therapeutic target
for metabolic disease. Although AMPK regulates diverse meta-
bolic processes, surprisingly few studies have interrogated the
full repertoire of AMPK biological targets and pinpointed their
specific phosphorylation sites. One such study used a chemical
genetics approach and confirmed six AMPK substrates (Banko
et al., 2011). However, more global approaches focusing on ex-
ercise are yet to be undertaken.Inc.
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Figure 1. Acute Exercise-Regulated Phosphoproteome in Human Skeletal Muscle
(A) Experimental design of the phosphoproteomic analysis of exercise in human muscle is shown. Muscle biopsies pre-exercise and post-exercise from four
healthy males were collected. Protein was extracted and digested with Lys-C/trypsin, and peptides were isobarically labeled with iTRAQ or TMT tags. Phos-
phopeptides were enriched by titanium dioxide chromatography and sequential elution from immobilized metal ion affinity chromatography (SIMAC). The un-
bound non-phosphorylated fraction and phosphorylated fraction were further separated by hydrophilic interaction liquid chromatography (HILIC) into 12–16
fractions. Each fraction was analyzed by nano-ultra high-pressure liquid chromatography coupled to tandem MS (nanoUHPLC-MS/MS) on a Q-Exactive MS
operated in DDA.
(B) Volcano plot showing the median phosphopeptide log2 fold change (post-exercise/pre-exercise) plotted against the log10 p value highlighting significantly
regulated phosphopeptides (blue; p < 0.05, n = 4, moderated t test). Dotted lines indicate (+/) 1.5-fold change (log2 = 0.58).
(C) Pearson’s correlation analysis of phosphopeptide fold-change quantification (post-exercise/pre-exercise) between the four subjects is shown.
(D) Summary of the quantified and regulated proteome and phosphoproteome is shown.We report a global phosphoproteomic analysis of acute exer-
cise signaling in human skeletal muscle revealing the com-
plexity of the exercise signaling network. We quantified 8,511
unique phosphorylation sites, of which 12% were regulated
with exercise, including more than 900 sites not previously an-
notated as exercise responsive. By combining the human exer-
cise phosphoproteome, two additional targeted AMPK assays,
and bioinformatics analyses, including machine learning, we
have identified eight highly predicted AMPK substrates that
are involved in mitochondrial function, vesicle transport, and
excitation-contraction coupling. One substrate, A kinase an-
chor protein 1 (AKAP1), was shown to regulate mitochondrial
respiration via AMPK-dependent phosphorylation, highlighting
the utility of the exercise-regulated phosphoproteome. These
data serve as a rich resource for future studies into how
acute exercise orchestrates skeletal muscle mechanics and
metabolism.Cell MRESULTS
Acute Exercise-Regulated Phosphorylation in Human
Skeletal Muscle
Four healthymale volunteers (age, 24–27; BMI, 24.2–25.9 kg/m2;
maximal oxygen uptake [VO2 max], 48–59 ml/kg/min; maximal
watts [W] produced [Wmax], 320–375 W) underwent a single
bout of high-intensity cycle exercise at 85% increasing to 92%
Wmax for 9–11 min (Figure S1). Quantitative phosphoproteomic
analysis of muscle biopsies pre-exercise and post-exercise was
performed with multiplexed isobaric labeling and phosphopep-
tide enrichment coupled to tandem mass spectrometry (MS)
(Figure 1A). The analysis also included quantification of non-
phosphorylated peptides to investigate changes in protein abun-
dance. A total of 11,903 unique phosphopeptides (8,511 phos-
phosites with >90% localization probability) and 4,317 proteins
was quantified in all four subjects (Figure 1B; Tables S1 andetabolism 22, 922–935, November 3, 2015 ª2015 Elsevier Inc. 923
S2). The phosphorylation profile in each subject was highly
reproducible with an average Pearson’s correlation coefficient
r = 0.72 (Figure 1C). We identified 1,322 phosphopeptides
(1,004 phosphosites with >90% localization probability) signifi-
cantly regulated with acute exercise (Figure 1D; Table S1;
adjusted p < 0.05, moderated t test). Only five proteins were
quantified as having altered abundance following acute exer-
cise, indicating that changes in phosphopeptide abundance
are a direct result of phosphorylation. Of the regulated phospho-
sites, 592 were annotated in PhosphoSitePlus (Hornbeck et al.,
2012), while 412 have not been annotated.
Kinase Regulation in Response to Acute Exercise
Pathway overrepresentation analysis of the phosphoproteins
containing exercise-regulated phosphosites revealed an enrich-
ment of signaling pathways regulating a broad range of cellular
functions, underpinning the pervasive role of exercise in human
biology. This included well-characterized exercise-regulated
signaling pathways such as AMPK, MAPK, PKA, mTOR, S6 ki-
nase, and Ca2+ signaling, as well as pathways with a less defined
role in exercise including CDK and ILK signaling (Table S3).
Phosphorylation of proteins involved in insulin receptor, cell-
junctional and cytoskeletal signaling, including Rho and actin
signaling, was also significantly enriched. In addition, since ki-
nases themselves are often modulated by phosphorylation, we
determined which kinases were phosphorylated in response to
exercise. A total of 45 protein kinases contained at least one
regulated phosphorylation site, including kinases known to be
activated during exercise such as AMPK, MAPK, and CAMK2
(Table S1).
We next retrieved site-specific information for experimentally
annotated kinase-substrate relationships from PhosphoSite-
Plus. Significantly regulated phosphosites were first assigned
to their upstream kinase. The relative changes in substrate phos-
phorylation were then used to infer kinase activity. Of the 592
identified phosphosites in PhosphoSitePlus, experimental evi-
dence for the upstream kinase(s) was reported for only 79 sites
on 66 proteins (Table S4). This analysis revealed the extensive
breadth of kinases regulated by exercise comprising 15 kinases
that had two or more substrates: AMPK, MAPKAPK2, p38
MAPK, ERK, RSK, PKA, Akt, CaMK, mTOR, ROCK, PKC, CDK,
EEF2K, Src kinase family members SRC/FYN/LCK/YES, and
PDHK (Figure 2A). Phosphorylation of many of these substrates
was confirmed by immunoblotting using site-specific antibodies
(Figure 2B). Next, we generated an integrative network of the ex-
ercise-regulated kinase interactome (Figure 2C). Experimentally
validated human protein-protein interactions were retrieved from
the Human Protein Reference Database (HPRD) and STRING
databases, and kinase-substrate relationships were retrieved
from PhosphoSitePlus. This kinome network highlights the com-
plexity and interconnectivity of the exercise signaling landscape
that are not apparent from analyzing kinase-substrate relation-
ships alone.
Predicting AMPK Substrates
The acute exercise kinome network highlighted multiple inter-
connected nodes involving diverse families of kinases. However,
one of the most functionally relevant kinases associated with ex-
ercise, AMPK, did not feature prominently. Despite the well-es-924 Cell Metabolism 22, 922–935, November 3, 2015 ª2015 Elseviertablished activation of AMPK in exercise, only six bona fide
substrates were quantified and regulated. Since hundreds of
the exercise-regulated phosphosites identified have unknown
upstream kinases, we sought to expand the list of validated
AMPK substrates. A total of 516 exercise-regulated phospho-
sites reported in PhosphoSitePlus had no annotated upstream
kinase. A further 412 exercise-regulated phosphosites were
absent from the database, amounting to 928 regulated phos-
phosites with no associated upstream kinase. Identification
of kinases for these substrates will likely yield insights into
mechanisms of exercise action. To begin to identify kinases for
these substrates, we performed bioinformatic analysis using
NetworKIN and NetPhorest, which combines consensus sub-
strate motif analysis with protein-protein interaction databases
(Linding et al., 2008).
Following prediction thresholding with PhosphoSiteAnalyzer
(Bennetzen et al., 2012), 21 kinase groups were predicted for
575 of these phosphosites. Using phosphosite fold changes, a
kinase-substrate set enrichment analysis revealed that 11 ki-
nases were associated with greater activity and two kinases
were associated with decreased activity following exercise (p <
0.05; Kolmogorov-Smirnov test; Table S5). Kinase groups with
greater activity included two well-characterized kinases associ-
ated with the exercise response, PKA and CaMKII. A large frac-
tion of phosphorylation sites that were increased with exercise
contained basophilic amino acids in the 2 and 3 positions
and included predictions for kinases with a less defined role in
exercise, including DMPK, PIM, PAK, and NEK. MAPK and
CDK were associated with decreased activity following exercise
with predicted substrates containing proline in the +1 position of
the phosphorylation site. Surprisingly, we identified only five pre-
dicted AMPK substrates by NetworKIN. These included four
known substrates: ACC1, ACC2, Raptor, TBC1D1, and a previ-
ously predicted substrate GPHN (Banko et al., 2011).
To extract additional AMPK substrates from the human exer-
cise phosphoproteome, we integrated these data with data
from additional, more AMPK-focused assays. In our first assay,
SILAC labeled L6 myotubes were treated with or without the
AMPK activator 5-Aminoimidazole-4-carboxamide-1-b-D-ribo-
furanoside (AICAR; 2 mM; 30 min; n = 4). Quantitative phos-
phoproteomic analysis was performed with phosphopeptide
enrichment coupled to tandem MS (Figure 3A). The analysis in-
cluded quantification of non-phosphorylated peptides to investi-
gate changes in protein abundance (n = 3). A total of 17,212
unique phosphopeptides was identified (12,695 phosphosites
with >90% localization probability), and 7,464 phosphopeptides
were quantified in two out of four biological replicates (7,421
phosphosites with >90% localization probability) (Figures 3B
and 3C; Table S6). At least 6,844 proteins were identified with
3,938 quantified in two out of three biological replicates (Table
S7). No significant changes in protein abundancewere detected.
AICAR significantly modulated 132 unique phosphopeptides
(107 phosphosites with >90% localization probability) relative
to control, of which 65 and 42 phosphosites were upregulated
and downregulated, respectively (adjusted p < 0.05, moderated
t test; Figure 3C; Table S6). Among AICAR upregulated sites
were known AMPK substrates including S231 on TBC1D1, S79
on ACC1, S637 on ULK1, and S108 on the AMPKb1 subunit
(Figure 3D). To obtain an overview of the signaling pathwaysInc.
PP
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P P P P P
P
P
P
P
P
R1C
OSBP
L11
PPP1
MAR
CKS
P2L
TBCAMPK
1D1
MAPK
N11
AKT
CTNNB1
MAP
2K4
TM1
ROCK
ARHG
PPP2
PPP1PKA
STMN1
STOM
PHKA1
PYGB NEDD1
PDHA1
NDRG2
LMR ILKCHK
PDHA2
PDHK
PLK SGK
HN1L
DBNL CDK
ULK1
ACACA
RPTOR
ACACB
HSPB1
PARN EXOC7
CRYAB
MAST1
TSC2
P38
GYS1
SPAG9
MAPT
HSPB8
MTOR
IRS1
RSK
FLNA
BAG3
CTNND1
SRC
FYN
AKT LCK
p70S6K
EEF2K
FHOD1
WNK1
FXR1
HIVEP2
OXSR1
PKC
TBXA2RVIM
TPPP
ARPP19
MYLK
TH
PAK
PKG
PLN
CAMK2
DAPK2
SPR
APPL1
HSPB6
NDE1
CDK16
PLCB3
ERK
APK2
R14C
TBC
1D4
1S1
PTP
SQS
UBA
DIA
PPP1
R5D
R1A
S337 BCKDHA
S189 OSBPL11
S397 NEDD1
S15 PYGB
T73 PPP1R14C
S420 FXR1
S291 PDHA2
S291 PDHA2
S232 PDHA1
Y546 PTPN11
Y416 SRC/FYN/LCK/YES
T348 EEF2KS500 EEF2K
S454 UBAP2LT150 MARCKSS275 DBNLS97 HN1LT269 SQSTM1
T586 SPAG9
S222 HIVEP2
S268 CTNND1
S34 ARHGDIA
S331 TBXA2R
S7 VIM
S1374 R
OCK2
S1137 
FHOD1
S332 
NDRG
2
T330
 NDR
G2
T348
 NDR
G2
S344
 NDR
G2
T28
5 BA
G3
S28
9 B
AG3
T17
 PL
N
S34
3 C
AM
K2B
S55
2 C
TNN
B1
S21
3 S
PR
S80
 MA
P2K
4
S62
9 IR
S1
T64
2 T
BC
1D4
S31
8 T
BC
1D4
T246 AKT1S1
S73 VIM
S16 HSPB6
S71 TH
S110 CDK16
S1105 PLCB3
T34 PPP1R1C
S573 PPP2R5D
S306 NDE1
S410 APPL1
T35 PPP1R1A
S104 ARPP19
S1018 PHKA1
S16 PLN
S10 STOM
S63 STMN1
S531 MAPT
S159 TPPP
S2152 FLNA
S722 RPTOR
T522 MAPT
S24 HSPB8
S1258 MAST1
S250 EXO
C7S1
779 MY
LKS
645 GY
S1S5
9 CRY
AB
Y182
 MAP
K14
T180
 MAP
K14
T180
;Y18
2 MA
PK1
4
S15
 HS
PB1
S12
54 T
SC2S8
2 H
SPB
1
S55
7 PA
RN
T33
4 M
APK
APK
2
S69
4 U
LK1
S72
2 R
PTO
R
S70
4 T
BC
1D4
S23
7 T
BC
1D1
S22
2 A
CA
CB
S80
 AC
AC
A
PKA
AM
PK
AKT
CA
M
KI
I
m
TO
R
CDK
MA
PK
AP
K2 P38
ERK
RSK
ROC
K
PKC
EEF2K
Src
PDHK
PAK
ILK
LM
R
PLK
C
H
K
B
C
K
D
+1.
5 f
ol
d
-1.5
fo
ld
A B
C
increased direct phosphorylation
decreased direct phosphorylation
known protein-protein interaction
_ _ _ _+ + + +
ACC pS80
AMPKα pT172
AMPKα
AS160 pS704
AS160
Akt pT308
Akt pS473
Akt
AS160 pT642
ERK1/2 pT202/Y204
p38 pT180/Y182
CaMK2B pT287
PKCpan pS660
Raptor pS792
14-3-3
PRAS40 pT246
p90RSK pS380
NDRG1 pT346
ULK1 pS757
Exercise
Subject1 2 3 4
(legend on next page)
Cell Metabolism 22, 922–935, November 3, 2015 ª2015 Elsevier Inc. 925
regulated by AICAR, phosphoproteins containing significantly
regulated phosphosites were subjected to pathway analysis (Ta-
ble S8). Significantly enriched pathways included actin cytoskel-
eton signaling, PPAR activation, ILK, cAMP signaling, and AMPK
signaling.
We adapted a machine learning-based model previously
developed by our group for predicting kinase-substrate relation-
ships (Humphrey et al., 2013) to predict AMPK substrates from
the L6 phosphoproteomics data. A curated positive training set
was obtained, and model prediction scores were calculated
based on (1) a motif score where the amino acid sequence sur-
rounding the phosphorylated residue matches the AMPK con-
sensus motifs (Gwinn et al., 2008) and (2) the fold change of a
specific phosphorylation site in response to AICAR (Figure 3D;
Table S9). Multiple candidate AMPK substrates were identified
and cross-referenced with the human exercise-regulated phos-
phoproteome. To integrate phosphoproteomics data across
species, we developed a web application, PhosphOrtholog,
capable of mapping both annotated and non-annotated ortholo-
gous phosphorylation sites between human and rat proteins
based on pairwise sequence alignment (Chaudhuri et al.,
2015). Of the 1,004 human exercise-regulated phosphosites,
only 55 orthologous rat phosphosites annotated in PhosphoSite-
Plus were also identified in rat L6 myotubes. PhosphOrtholog
performed considerably better and mapped an additional 103
phosphosites identified in both the humanmuscle and rat L6my-
otubes, which were not annotated in PhosphoSitePlus (Table
S10). Six candidate AMPK substrates regulated by exercise
and AICARwere identified based on the prediction model. These
comprised two known AMPK substrates TBC1D1 S237 (rat
S231), ACC1 S80 (rat S79), and candidate substrates AKAP1
S107 (rat S103), stromal interaction molecule 1 (STIM1) S257
and S521, and VAMP-associated protein A (VAPA) S164.
To validate that these candidate phosphorylation sites were
bona fide AMPK substrates, we performed a whole-cell lysate
AMPK in vitro kinase analysis, based on Knight et al. (2012),
and combined this with targeted phosphopeptide quantification
using data-independent acquisition MS (DIA-MS). This strategy
consisted of three steps (Figure S2): (1) spectral library construc-
tion, (2) purification of active AMPK, and (3) global AMPK in vitro
kinase analysis. A spectral library containing 35,897 phospho-
peptides (22,772 phosphosites with >90% localization probabil-
ity) was generated using phosphopeptide enrichment coupled to
tandem MS from HEK293 cells treated with the AMPK agonists
AICAR and A-769662 (Table S11). This spectral library contained
368 of the 1,004 exercise-regulated phosphopeptides identified
in human muscle. A separate batch of HEK293 cells was lysed
in kinase buffer and treated with a phosphatase and pan-kinase
inhibitor cocktail. The lysate was treated with (1) buffer alone, (2)Figure 2. Site-Specific Kinase-Substrate Regulation in Response to Ac
(A) Significantly regulated phosphopeptides (+/ 1.5-fold change, p < 0.05, n =
upstream kinases. Co-regulation of substrate phosphorylation sites (inner dotte
phorylation) provides insights into kinase activity in response to exercise.
(B) Muscle biopsy lysates from four subjects pre-exercise and post-exercise we
(C) An integrative network of the exercise-regulated kinase interactome was gen
annotated kinase-substrate relationships. Direct increases (green arrows) and de
represent protein-protein interactions. Colors represent kinases with exercise-reg
contain regulated phosphorylation sites.
926 Cell Metabolism 22, 922–935, November 3, 2015 ª2015 Elsevieractive AMPK, and (3) active AMPK in the presence of the AMPK
inhibitor, compound C. Lysates were used for either immuno-
blotting or phosphopeptide enrichment coupled to DIA-MS.
Immunoblotting confirmed AMPK phosphorylation of S80 on
ACC and S792 on Raptor, which were partially attenuated by
compound C despite the reduced efficacy of this drug in the
presence of elevated AMP concentrations likely to be present
in the cell lysate (Zhou et al., 2001) (Figure 4A). Targeted data
extraction (Gillet et al., 2012) on the single-shot DIA-MS data us-
ing the 368 exercise-regulated phosphopeptides resulted in
quantification of 69 phosphopeptides (mProphet q value < 0.01
and CV < 20%) (Table S12). Ten phosphopeptides were signifi-
cantly increased by AMPK addition relative to control, and the
majority were attenuated by compound C (Table S12). These
included known AMPK substrates ACC1 S80 (ACACA; Fig-
ure 4B), an additional AMPK phosphorylation site on Raptor,
S722 (RPTOR; Figure 4C), and several exercise-regulated sites
(Figures 4D–4I). We performed multiple sequence alignment of
exercise-regulated phosphopeptides that were significantly
increased by AMPK in the DIA-MS data or AICAR in L6 cells (Fig-
ure 5) with previously characterized AMPK consensus motifs
(Gwinn et al., 2008). Seven known AMPK substrates regulated
by exercise (black circles) aligned with the consensus motif as
expected. Eight substrates regulated with exercise were con-
firmed with AICAR stimulation and/or DIA-MS (green circles).
Of these, six were confirmed by DIA-MS (black diamonds [A]).
An additional six phosphosites previously predicted as AMPK
substrates (Banko et al., 2011) were regulated by exercise (yel-
low circles).
AKAP1 Is a Mitochondrial AMPK Substrate
AKAP1 is a mitochondrial scaffold protein that binds mitochon-
drial-targeted PKA (Merrill and Strack, 2014) and other kinases
such as PKC (Greenwald et al., 2014). To test the possibility
that AKAP1 may play a role in mitochondrial AMPK signaling,
we generated a phospho-specific antibody to assess the pre-
dicted AMPK phosphorylation site S103 on AKAP1. This anti-
body recognized AKAP1 phosphorylated at S103 specifically in
rodents. An increase in AKAP1 S103 phosphorylation induced
by A-769662 was detected in HEK293 cells expressing FLAG-
tagged mouse AKAP1 WT, but not empty vector (EV) FLAG or
FLAG-tagged AKAP1 S103A phospho-dead mutant (Figure 6A).
To confirm AMPK as the AKAP1 S103 kinase, in vitro kinase
assays were performed on immunoprecipitated AKAP1 in the
absence or presence of active AMPK a1b1g2. AMPK increased
AKAP1 S103 phosphorylation similarly to ACC S79 and this
was abolished by compound C (Figure 6B). Similar to the
characteristic increase in ACC S79 phosphorylation, AKAP1
S103 phosphorylation was increased following incubation ofute Exercise
4, moderated t test) were clustered according to PhosphoSitePlus-annotated
d circle = decreased phosphorylation; outer dotted circle = increased phos-
re immunoblotted for kinases and substrates in the phosphoproteomics data.
erated using experimentally validated human protein-protein interactions and
creases (red arrows) in substrate phosphorylation are shown, and dotted lines
ulated activity, as shown in (A). Additional kinases (gray) and substrates (white)
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Figure 3. AMPK Substrate Prediction Using AMPK-Activated Phosphoproteomics
(A) Experimental design of the phosphoproteomic analysis of AICAR stimulation is depicted. 2-plex SILAC labeled L6 myotubes were treated with or without
AICAR (n = 4 with 2 label switching experiments). Proteins were extracted and digested with trypsin. Peptides were fractionated by strong cation exchange (SCX)
chromatography and phosphopeptides enriched using titanium dioxide chromatography. An aliquot of the non-phosphorylated peptides was fractionated by
HILIC. Phosphopeptide and non-phosphopeptide fractions were analyzed by nanoUHPLC-MS/MS on a Q-Exactive MS operated in data-dependent acquisition
followed by MaxQuant analysis.
(B) Volcano plot showing median phosphopeptide log2 fold change (AICAR/basal) plotted against log10 p value highlighting significantly regulated phospho-
peptides (blue; *p < 0.05, n = 4, moderated t test). Dotted lines indicate (+/) 1.5-fold change (log2 = 0.58).
(C) Summary of the quantified and regulated proteome and phosphoproteome is shown.
(D) AMPK substrate prediction using the AICAR-regulated L6 myotube phosphoproteome. The model was trained based on the primary amino acid motif
surrounding the phosphosites and magnitude of upregulation by AICAR (AICAR-regulated sites in blue) using known AMPK substrates quantified (red).L6 myotubes with either AICAR, A-769662 or 2,4-dinitrophenol
(DNP) (Figure 6C). This A-769662 induced increase in AKAP1
S103 phosphorylation was ablated with siRNA knockdown of
the catalytic a1 and a2 subunits of AMPK (siAMPKa) compared
with cells transfected with scrambled control siRNA (siScramble;
Figure 6D). Consistent with these findings, AICAR-dependentCell Mphosphorylation of AKAP1 S103 was absent in soleus muscle
from mice expressing kinase dead AMPKa2 (Figure 6E). It
was notable that ACC phosphorylation was not inhibited to
the same extent as AKAP1 in kinase dead AMPKa2 muscle,
possibly reflecting an underlying subtlety to AMPK regulation
that remains to be found. It was suggested that there may beetabolism 22, 922–935, November 3, 2015 ª2015 Elsevier Inc. 927
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Figure 4. AMPK Substrate Prediction Using
Data-Independent MS Analysis of a Global
AMPK In Vitro Kinase Assay
(A) Immunoblot analysis of known AMPK sub-
strates (ACC and Raptor) in HEK293 lysates sub-
jected to a global AMPK (a1b1g2) in vitro kinase
assay ± active AMPK and the AMPK inhibitor
compound C.
(B–I) Targeted quantification (mean ± SD, one-way
ANOVA corrected for multiple testing, *p < 0.05,
**p < 0.01, ***p < 0.005, n = 3) of phosphopeptides
from HEK293 lysates subjected to a global AMPK
(a1b1g2) in vitro kinase assay using nanoUHPLC-
MS/MS on a Q-Exactive MS operated in DIA.an alternate ACC kinase, but so far, attempts to identify this ki-
nase have not been successful (Dzamko et al., 2008). AKAP1
S103 phosphorylation, in addition to AMPK T172 and ACC
S79, was also increased in red quadricep muscles following
treadmill exercise in mice (Figure 6F).
We next examined mitochondrial localization of AMPK and
AKAP1. A-769662 increased AMPK T172 and ACC S79 phos-
phorylation in the whole-cell lysate and non-mitochondrial cyto-
plasmic fractions isolated from L6 myotubes (Figure 6G). As
expected, AKAP1 and phospho-S103 AKAP1 were highly en-
riched in the mitochondrial fraction. Immunofluorescence con-
firmed that FLAG-tagged AKAP1 WT and the AKAP1 S103A
mutant were primarily localized to mitochondria (Figure 6H).
Phospho-AMPK was also highly enriched in the mitochondrial
fraction, while the majority of immunoreactive AMPKa was iden-
tified in the non-mitochondrial cytoplasmic fraction. Use of
AMPK isoform-specific antibodies revealed that AMPKa2 was
highly enriched in the mitochondrial fraction compared with
AMPKa1. In addition, mitochondrial detection of AMPKa1 was
increased upon A-769662 stimulation. Interestingly, both ACC1
and ACC2 were primarily localized to the non-mitochondrial
cytoplasmic fraction. However, similar to AMPK, the minor
pool of ACC localized at the mitochondria was robustly phos-
phorylated following AMPK activation (Figure 6G).
AKAP1 S103 Phosphorylation via AMPK Facilitates
Mitochondrial Respiration
Considering the mitochondrial localization of AKAP1 and regula-
tion of mitochondrial energy utilization by AMPK, we next used
siRNA knockdown to explore their role in this process further.
Knockdown of AMPKa in L6 myoblasts significantly reduced
mitochondrial respiration in the presence of both bovine serum928 Cell Metabolism 22, 922–935, November 3, 2015 ª2015 Elsevier Inc.albumin (BSA) and palmitate (Figures 7A–
7C). Similarly, knockdown of AKAP1 (siA-
KAP1; Figure 7D) significantly impaired
mitochondrial respiration (JO2; Figure 7E)
andoxygenconsumption (OCR;Figure7F)
in the presence of BSA compared with
myoblasts transfected with siScramble.
Similar data were obtained using the
oxygraph-2K respirometry systems (O2K;
Figure 7E) and extracellular flux analyzer
(XF24; Figure 7F). In addition, mitochon-
drial palmitate oxidation was blunted in
myoblasts transfectedwith siAKAP1 comparedwith those trans-
fected with siScramble (Figures 7E and 7F).
To examine the role of AKAP1 S103 in mitochondrial respira-
tion, we assessed whole-cell respiration in L6 myoblasts ex-
pressing either FLAG-tagged AKAP1 WT or the AKAP1 S103A
mutant (Figure 7G). Using the O2K, we observed the expected
increases in respiration induced by palmitate and A-769662 in
L6 myoblasts transfected with EV FLAG (Figure 7H). Strikingly,
L6 myoblasts expressing S103A displayed impaired A-769662-
stimulated respiration compared with cells expressing either
EV FLAG or WT AKAP1 (Figure 7I). Similar to our siAKAP1 find-
ings, L6 myoblasts expressing the S103A AKAP1 mutant dis-
played impaired OCR compared with those expressing WT
AKAP1 in the presence of BSA and palmitate (Figure 7J).
DISCUSSION
This study represents a major advance in our understanding of
how acute exercise signaling affects muscle biochemistry and
physiology. Our use of unbiased, global phosphoproteomics
has shed light on the complexity of exercise signaling. In this
study, we have achieved three major goals. First, we provide a
comprehensive map of the acute high-intensity exercise sig-
naling network in human muscle and used this together with
protein-protein interaction databases to generate an exercise
kinome network. The entire network comprised over 900 exer-
cise-regulated phosphorylation sites with no known upstream
kinase. Second, we identified eight exercise-regulated AMPK
substrates using a combination of global MS-based phospho-
proteomics in muscle cells, machine learning AMPK substrate
prediction, and integrated substrate validation using targeted
DIA-MS analysis in HEK293 cells. Finally, we unveiled a function
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Figure 5. AMPK Consensus Motif and Substrate Sequence
Alignment
AMPK consensus motif derived from Gwinn et al. (2008) with multiple
sequence alignment of exercise-regulated phosphosites in human muscle
(Human Exercise) is displayed. The alignment shows known AMPK substrates
(black circles), internally predicted AMPK substrates with validation (blue cir-
cles) in either AICAR stimulated Rat L6 myotubes (Rat AICAR) or global AMPK
in vitro kinase analysis in HEK lysates (black diamonds [A]), and externally
predicted AMPK substrates from Banko et al. (2011) (orange circles).of AMPK in mitochondrial respiration via phosphorylation of
AKAP1.
The presence of a small number of large abundant contractile
proteins, which account for over 50% of tissue mass, presents
a considerable challenge for muscle biochemistry (Geiger
et al., 2013). By comparison to other tissues, a lower number
(3,500) of muscle phosphorylation sites have been reported
using MS (Højlund et al., 2009; Lundby et al., 2012; Zhao et al.,Cell M2011). In this study, we combined improved phosphopeptide
enrichment strategies with multiplexed isobaric labeling and
high resolution separation coupled to tandem MS to identify
>8,500 phosphorylation sites, 12% of which were significantly
regulated with exercise. To achieve this robust exercise res-
ponse, we utilized a high-intensity acute exercise regimen in
humans, which likely engagedmanymuscle fibers and produced
a robust signaling response. The paired experimental design
combined with our optimized biopsy approach resulted in a
highly reproducible exercise-induced phosphorylation response
(Figure 1).
Exercise imposesmetabolic, oxidative, andmechanical stress
on muscle due to increased energy turnover. These stress path-
ways play a major role in the initiation of exercise signaling (re-
viewed in Egan and Zierath, 2013), culminating in the regulation
of numerous kinases including AMPK, PKA, CaMK, and MAPK.
While we observed robust activation of these known kinases,
this represented only a fraction of the regulated sites (10%)
identified in the present study. Thus, the vast majority of the ex-
ercise-regulated phosphosites reported here (900 sites) have
not previously been associated with the exercise response.
This likely reflects the role of exercise to perturb multiple stimuli
throughout the body to initiate signaling cascades inmuscle. Our
data further highlight exercise signaling pathways implicated in
muscular dystrophy and associatedmuscle pathology, including
kinases such as DMPK, ILK, and CDK. Interestingly, the exercise
kinome network in skeletal muscle highlights many nodes
involved in oxidative and/or intracellular stress, including the
p38 MAPK pathway, Wnk1/OSR1, DMPK, PKD, Aurora, MST3,
PAK, ATM, PIM, Src kinase family members, and DAPK. Consis-
tent with this, exercise-induced reactive oxygen species pur-
portedly plays a major role in the beneficial effects of exercise
(Ristow et al., 2009). The effects of exercise on mTORC1/2
were of particular interest with altered phosphorylation observed
in multiple components of this complex including RagC, DEP-
TOR, DAPK2, and the mTORC1 binding protein LARP1. Based
on the direction of change in both Akt and mTORC1/2 sub-
strates, our data are consistent with a model whereby exercise
represses biosynthetic pathways to conserve substrates for en-
ergy production. However, there is no consensus concerning the
effect of various exercise protocols on Akt activity (Thorell et al.,
1999; Widegren et al., 1998; Wojtaszewski et al., 2001). We
observed not only decreased Akt phosphorylation, but also
reduced phosphorylation of a range of Akt substrates after exer-
cise indicative of reduced Akt kinase activity. Therefore, we are
confident that Akt kinase activity was reduced with our exercise
protocol. The pathways described above, along with 45 protein
kinases and 16 transcription factors that we observed to be
phosphorylated during exercise, warrant further investigation
(Table S1).
Given the known activation of AMPK during exercise and its
suggested therapeutic potential for metabolic disease, there is
considerable interest in identifying additional AMPK substrates.
One of the most comprehensive studies was a chemical genetic
screen that identified 28 potential AMPK substrates and vali-
dated six of these (Banko et al., 2011). In addition, a recent study
applied antibody-based affinity proteomics to identify 57 candi-
date AMPK substrates in primary hepatocytes and validated two
substrates (Ducommun et al., 2015). Another previous screenetabolism 22, 922–935, November 3, 2015 ª2015 Elsevier Inc. 929
utilized a 2D in vitro screening approach to identify proteins that
interact with the AMPK a2b2g1 isoform (Klaus et al., 2012). Here,
we employed physiological activation of exercise pathways,
combined with extensive interrogation of the AMPK signaling
network using complementary MS techniques and bioinformatic
approaches, to identify eight high-confidence exercise-regu-
lated AMPK substrates. We also identified six previously pre-
dicted AMPK substrates including GPHN, GOLGA4, IGF2R,
TNIK, MINK1, and PPP1R12B (Banko et al., 2011).
Strikingly, five AMPK substrates are associated with the ER
and Golgi apparatus (STIM1, VAPA, GPHN, GOLGA4, and
IGF2/CIMPR), highlighting unidentified roles for AMPK in ER/
Golgi function such as vesicle trafficking and Ca2+ regulation.
STIM1 regulates store-operated Ca2+ entry and functions as an
ER Ca2+ sensor. In response to depletion of intracellular Ca2+
stores STIM1 undergoes oligomerization and conformational
changes triggering its interaction with the Ca2+ release activated
channel (CRAC) Orai1 at the plasma membrane to facilitate Ca2+
entry into the cell (Soboloff et al., 2012). Interestingly, the AMPK-
regulated S257 phosphosite on STIM1 is adjacent to the pro-
posed hinge region, suggesting that AMPK likely regulates
STIM1 intramolecular and/or intermolecular dynamics, thereby
affecting STIM1-Orai1 complex activation to regulate Ca2+ influx
during acute exercise (Soboloff et al., 2012). AMPK-regulated
phosphorylation of VAPA suggests additional unappreciated
mechanisms of lipid and glucose transport regulation by
AMPK. We also validated eight additional exercise-regulated
AMPK substrates associated with other organelles (AKAP1,
AGPAT9, SLC12A2, CTNND1, AKAP13, TNIK, MINK1, and
PPP1R12B). Collectively, these studies expand the repertoire
of AMPK biological functions to include (1) vesicle transport, (2)
beta-catenin and Wnt signaling (TNIK, MINK1, CTNND1), (3) po-
tassium and chloride transport (SLC12A2), which is crucial for
sustaining exercise (Clausen, 2003), (4) calcium homeostasis
and excitation contraction coupling (STIM1), (5) myosin phos-
phorylation (PPP1R12B), (6) lipid signaling (AGPAT1), and (7)
mitochondrial signaling (AKAP1).
The identification of AKAP1 as an AMPK substrate was of inter-
est given its mitochondrial localization and the known role of
AMPK in mitochondrial energetics. Currently, the mitochondrial
function of AMPK is thought to be primarily conveyed via AMPK-
dependentphosphorylationofACC to regulatemitochondrial fatty
acid import andoxidation.AKAP1 isexpressedathigh levels inhu-
manmuscle, heart, and adipose tissue, and it has been implicated
in fatmetabolism (Bridges et al., 2006). Here, wedemonstrate that
AKAP1 is a bona fide AMPK substrate in muscle that plays an
important role in AMPK regulated mitochondrial respiration.
Consistent with this, knockdown of AKAP1 impairs mitochondrial
membrane potential and ATP production (Livigni et al., 2006), and
overexpression of AKAP1 increases cellular oxygen utilization
(Merrill and Strack, 2014). Intriguingly, the expression of AKAP1
is reduced 4-fold in adipose tissue from obese individuals (Mar-
rades et al., 2010). However, we were unable to detect any differ-
ence between AKAP1 mRNA levels in human muscle from lean
and obese individuals (data not shown).
The precise mechanism by which AKAP1 phosphorylation by
AMPK regulates mitochondrial signaling and function is not un-
derstood. Phosphorylated AMPK is enriched in mitochondria
together with AKAP1 in muscle cells (Figure 6G). However, we930 Cell Metabolism 22, 922–935, November 3, 2015 ª2015 Elsevierwere unable to detect a direct interaction between these proteins
(data not shown). Additional exercise-regulated phosphosites
were identified on AKAP1 including S128 and S592, which may
contribute to the observed phenotype or have alternative func-
tions. The present studies add to the growing body of evidence
showing cross-talk between AMPK and other kinases, including
PKA, potentially via AKAP1. For example, PKA phosphorylates
and inhibits AMPK to promote efficiency of the lipolytic response
in adipocytes (Djouder et al., 2010). Recent evidence highlights
roles for AKAP1 in kinase regulation, including PKC (Greenwald
et al., 2014) and Src (Livigni et al., 2006), that may impact mito-
chondrial function. Notably, exercise increased the activation
loop phosphopeptide common to Src kinase family members
Src, Fyn, Lck, andYes. An emerging concept for scaffold proteins
such as AKAP1 is their role in scaffold state switching to allow
signals and complexes to be insulated, amplified, and/or acceler-
ated within subcellular compartments such as mitochondria
(Greenwald et al., 2014). Mitochondria are dynamic organelles
that are continuously remodeled by fission and fusion. These
reactions are sensitive to physiological stimuli such as energy
stress and exercise to maintain mitochondrial integrity and sur-
vival (Bo et al., 2010). PKA bound to AKAP1 is known to inhibit
mitochondrial fission (Merrill and Strack, 2014). The accessibility
of PKA to AKAP1 is therefore expected to impact PKA’s ability
to inhibit fission. Therefore, AMPK-stimulated AKAP1phosphory-
lation in muscle during exercise and energy stress may limit
PKA accessibility to AKAP1 to promotemitochondrial remodeling
to meet metabolic demands. Additional mitochondrial phospho-
proteins we found to be regulated by exercise, including mito-
chondrial fission factor (MFF) and mitochondrial fission regulator
1-like (MFR1L), may also contribute to this dynamic remodeling
process. Notably, AKAP1 and MFR1L were regulated by both
exercise and AICAR, and MFF was recently validated as an
AMPK substrate (Ducommun et al., 2015). Therefore, AMPK
may have several functions in mitochondrial remodeling and en-
ergy homeostasis.
It is well recognized that a better mechanistic understanding of
exercise will provide a major step forward in harnessing the
immense therapeutic potential of this lifestyle intervention (Neu-
fer et al., 2015). It is our view that identifying the protein kinases
triggered in various tissues in response to exercise may provide
one tractable way of achieving this goal in view of the druggabil-
ity of this class of molecules. A notable feature of the present
study is that the exercise response is not governed by a single
kinase, but rather it involves the synchronous activation of a se-
ries of kinases. The challenge is to delineate which of these is
transmitting the beneficial effects of exercise with the long-
term goal of developing a combination kinase small molecule
cocktail that can be used to recapitulate some of the beneficial
effects of exercise in humans.
Taken together, the effort undertaken to map the exercise
phosphorylation landscape in human muscle has filled a crucial
gap in our understanding of muscle exercise signaling. For
example, the breadth of signaling pathways and kinases modu-
lated by exercise is far greater than previously appreciated. We
hope that similar studies investigating the effects of other exer-
cise protocols on other organs and other protein modifications
in a temporal fashion will further expand our knowledge of
cellular adaptation to exercise. Importantly, the combination ofInc.
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Figure 6. AKAP1 Is a Mitochondrial AMPK Substrate
(A) HEK293 cells expressing FLAG-tagged EV, AKAP1WT, or AKAP1 S103A were serum-starved for 2 hr, followed by ± 100 mMA-769662 for 30 min. Cell lysates
were immunoblotted with indicated antibodies.
(B) Activated AMPK a1b1g2 was added to immunoprecipitated AKAP1 or biotinylated ACC beads for 30min at 33
C ± compound C. In vitro kinase assay samples
were immunoblotted.
(C) L6 myotubes were serum starved for 2 hr, followed by incubation ± AMPK agonists AICAR (2 mM), A-769662 (100 mM), and DNP (200 mM) for 30 min. Lysates
were immunoblotted.
(D) L6 myoblasts were transfected with siScramble or siAMPKa. Cells were lysed after 72 hr and immunoblotted.
(E) Isolated soleus muscles fromWT and AMPKa2 kinase dead (KD) mice were incubated in vitro ± 2mMAICAR for 1 hr, andmuscle lysates were immunoblotted.
(F) WT mice were rested or subjected to treadmill exercise until exhaustion. Red quadricep muscles were isolated, and lysates were immunoblotted.
(legend continued on next page)
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Figure 7. AKAP1 and AMPK-Mediated S103
Phosphorylation Facilitate Mitochondrial
Respiration
(A) L6 myoblasts were transfected with siScramble
or siAMPKa. Cells were lysed after 72 hr and im-
munoblotted with indicated antibodies.
(B) Immunoblotting was performed in serum-
starved L6 myoblasts incubated with BSA or BSA-
conjugated palmitate (Palm.; 200 mM) ± 100 mM A-
769662 for 30 min. Immunoblots are representative
images from three to four independentexperiments.
(C) OCR was determined in serum-starved L6
myoblasts transfectedwith siScramble or siAMPKa
and incubatedwithBSAor Palm. (200 mM)± 100mM
A-769662.
(D–F) L6 myoblasts were transfected with siS-
cramble or AKAP1 siRNA (siAKAP1) (D). Cells were
lysed after 72 hr and immunoblotted. Respiration
(JO2 in (E) and OCR (F) was determined in serum-
starved L6 myoblasts transfected with siScramble
or siAKAP1 and incubated with BSA or Palm.
(200 mM) ± 100 mM A-769662.
(G–J) L6 myoblasts were transfected with FLAG-
tagged EV control, AKAP1 WT or AKAP1 S103A
mutant, incubated with BSA or Palm., and immu-
noblotting was performed (G), respiration (H and I)
and OCR (J) were measured. (I) Respiration is
shown as percentage increase with A-769662
stimulation in cells incubated with Palm.
Quantitative OCR and JO2 data represent mean ±
SEM, t test, *p < 0.05 versus siScramble BSA or
EV/WT control BSA, #p < 0.05 versus respective
siScramble or EV/WT control, n = 3–6.these data may provide a blueprint for future studies aimed at
developing exercise mimetic therapies for metabolic disease
treatment or prevention in the modern world. For example,
testing the ability of these unappreciated exercise-regulated ki-
nases to improve whole-body insulin sensitivity in the absence
of exercise, either through genetic or pharmacological studies,
will undoubtedly increase our understanding of metabolic health.
We anticipate that our unique, global approach to study exercise
signaling in human muscle will help unleash the full potential of
exercise in preventing obesity, type 2 diabetes, and other major
conditions that limit the health of our aging population.(G) L6 myotubes were serum starved for 2 hr, followed by stimulation ± 100 mM A769662 for 30 min. Followin
non-mitochondrial (Non-Mito) and mitochondrial (Mito) fractions were immunoblotted.
(H) L6 myoblasts expressing pMito-LSSmOrange (Mito) and either FLAG-tagged AKAP1 WT or AKAP1 S103A
later, and prepared for confocal microscopy (scale bar represents 10 mm).
Immunoblots are representative images from three to six independent experiments; quantitative AKAP1 pS10
andmean ±SEM is shown from n = 3–4 and n = 5mice, respectively, t test, *p < 0.05 versus basalWTmuscle (E
muscle.
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For complete details and MS data repository
information, see Supplemental Experimental
Procedures.
Human Subjects and Exercise
Four untrained healthy males (age, 24–27; BMI,
24.2–25.9 kg/m2, VO2 max, 48–59 ml/kg/min;
Wmax, 320–375 W) underwent a single bout ofhigh-intensity cycle exercise. Following warmup, subjects exercised for
6 min at 85% of Wmax and then to exhaustion at 92% of Wmax, which
occurred after 9- to 11-min total exercise time. Blood was obtained before
and during the last min of exercise, and two muscle biopsies were extracted
from the vastus lateralis immediately before and upon exercise cessation. Hu-
man studies were approved by the regional ethics committee in Denmark
(Journal number: H-1-2012-006) and carried out in accordance with the Decla-
ration of Helsinki II. Written informed consent was obtained from each subject.
Animals
Experiments comparing WT versus AMPK KD mice were approved
by the Danish Animal Experimental Inspectorate. Mouse treadmillg subcellular fractionation, whole cell lysate (WCL),
were reseeded 24 hr after transfection, fixed 24 hr
3 data in (E) and (F) are normalized to total protein,
) or rest (F), #p < 0.05 versus AICAR-stimulatedWT
experiments were approved by The University of Sydney Animal Ethics
Committee.
Phosphopeptide Enrichment and MS
Humanmuscle peptideswere labeledwith isobaric tags for relative or absolute
quantitation (iTRAQ) or tandem mass tags (TMT). L6 myotube SILAC labeling
was performed as previously described (Humphrey et al., 2013). Phosphopep-
tides were enriched using titanium dioxide followed by sequential elution from
immobilizedmetal ion affinity chromatography and fractionation by hydrophilic
interaction liquid chromatography (TiSH) (Engholm-Keller et al., 2012). Labeled
peptides were analyzed by MS using data-dependent acquisition (DDA) as
previously described (Humphrey et al., 2013). Phosphopeptides enriched
from the AMPK in vitro kinase assay were analyzed by data-independent
acquisition (DIA) (Gillet et al., 2012).
Phosphoproteomic Data Analysis
DDA data from human muscle were processed using Proteome Discoverer
v.1.4 against the human UniProt database. DDA data from rat L6 myotubes
were processed using MaxQuant v.1.4.0.8 (Cox and Mann, 2008) against
the rat UniProt database. All results were filtered to 1% FDRs. Median
values of peptide spectral matches (PSMs) for each phosphosite were
calculated using a script developed in Python. Bioinformatic analysis was
performed primarily in the R programming environment (http://www.
R-project.org). Protein quantification was performed using median values
of all PSMs of the protein group. Significantly regulated phosphopeptides
and proteins were determined using a moderated t test from LIMMA pack-
age in R (Smyth, 2004). Pathway analysis was performed with Ingenuity
Pathway Analysis (http://www.ingenuity.com), and prediction of kinase-sub-
strate relationships was performed with NetworKIN v.2.0 (Linding et al.,
2008), followed by processing and thresholding in PhosphoSiteAnalyzer
(Bennetzen et al., 2012).
All DIA data were processed using Skyline v.2.5.0.6157 (MacLean et al.,
2010), and targeted data extraction was performed essentially as described
(Gillet et al., 2012). Peak scoring models were trained based on mProphet
(Reiter et al., 2011) using a combination of scores and filtered to 1% FDR.
Significantly regulated phosphopeptides were determined by calculating the
moderated t-statistic using LIMMA package in R where eBayes method was
used for global variance shrinkage. Significance was defined by an adjusted
p value < 0.05.
Mitochondrial Respiration Assays
O2 consumption measurements were conducted using the OROBOROS
Oxygraph-2K (OROBOROS Instruments) or the XF24 and XFp analyzers (Sea-
horse Biosciences).
Statistical Analysis
Error bars represent mean ± SD (Figure 4) or mean ± SEM (Figures 6 and 7).
Statistical tests and experiment numbers are detailed in figure legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and twelve tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2015.09.001.
AUTHOR CONTRIBUTIONS
N.J.H. and B.L.P. designed experiments, performed MS sample preparation
and data analysis, and wrote the manuscript. N.J.H. performed AKAP1 biolog-
ical validation experiments. B.L.P. performed human muscle MS analysis and
in vitro kinase assays. R.C. performed bioinformatics analyses and integrated
AMPK substrate prediction. K.H.F.-W. performed respirometry experiments.
M.K. assisted with human MS sample preparation, and M.K. and T.E.J. per-
formed AMPKa2 KD mouse muscle analyses. S.J.H. performed L6 myotube
MS analysis, and S.J.H. and D.J.F. assisted with L6myotubeMS sample prep-
aration. P.Y. and R.J. performedmachine learning AMPK substrate prediction.
M.H. and S.T. assisted with AKAP1 biological validation and mutagenesis,
respectively. J.S. performed mouse exercise experiments. J.G.B. performedCell Mimmunofluorescence experiments. J.S., B.K., J.F.P.W., and D.E.J. contributed
to human exercise study design. B.K., J.F.P.W., and E.A.R. performed human
exercise studies. E.A.R. and D.E.J. designed experiments, established collab-
orations, provided expert guidance, and wrote the manuscript. All authors
approved the final version of the manuscript.
ACKNOWLEDGMENTS
We thank John D. Scott for providing AKAP1 cDNA; Bruce E. Kemp and Jona-
than S. Oakhill for AMPK a1, b1, and g2 cDNA; Kei Sakamoto for A-769662;
Merck for ACC1/2 antibodies; and Vladislav V. Verkhusha for pMito-LSSmOr-
ange. We thank Dorte E. Kristensen, James R. Krycer, and Xiao-Yi Zeng for
helpwith enrolling human subjects, Seahorse experimental design, andmouse
exercise experiments, respectively. This work was supported by National
Health and Medical Research Council (NHMRC) project grants GNT1061122
and GNT1047067 (D.E.J.) and grants from the Diabetes Australia Research
Trust (D.E.J., N.J.H., R.C.), Lundbeck Foundation, Novo Nordisk Foundation,
University of Copenhagen Excellence Programme for Interdisciplinary
Research (2016), and Council for Independent Research/Medicine (E.A.R.).
D.E.J. is an NHMRC Senior Principal Research Fellow. B.L.P is a recipient of
an NHMRC Early Career Fellowship, and S.J.H. is a recipient of a European
Molecular Biology Organization Long-Term Fellowship. P.Y. and R.J. are sup-
ported by the Intramural Research Program of the NIH, National Institute of
Environmental Health Sciences. The contents of the published material are
solely the responsibility of the individual authors and the Administering Institu-
tion and do not reflect the views of the NHMRC.
Received: February 26, 2015
Revised: June 29, 2015
Accepted: September 1, 2015
Published: October 1, 2015
REFERENCES
Banko, M.R., Allen, J.J., Schaffer, B.E., Wilker, E.W., Tsou, P., White, J.L.,
Ville´n, J., Wang, B., Kim, S.R., Sakamoto, K., et al. (2011). Chemical genetic
screen for AMPKa2 substrates uncovers a network of proteins involved in
mitosis. Mol. Cell 44, 878–892.
Bennetzen, M.V., Cox, J., Mann, M., and Andersen, J.S. (2012).
PhosphoSiteAnalyzer: a bioinformatic platform for deciphering phospho pro-
teomes using kinase predictions retrieved from NetworKIN. J. Proteome
Res. 11, 3480–3486.
Bo, H., Zhang, Y., and Ji, L.L. (2010). Redefining the role of mitochondria in ex-
ercise: a dynamic remodeling. Ann. N Y Acad. Sci. 1201, 121–128.
Bridges, D., MacDonald, J.A., Wadzinski, B., and Moorhead, G.B. (2006).
Identification and characterization of D-AKAP1 as a major adipocyte
PKA and PP1 binding protein. Biochem. Biophys. Res. Commun. 346,
351–357.
Chaudhuri, R., Sadrieh, A., Hoffman, N.J., Parker, B.L., Humphrey, S.J.,
Sto¨ckli, J., Hill, A.P., James, D.E., and Yang, J.Y. (2015). PhosphOrtholog: a
web-based tool for cross-species mapping of orthologous protein post-trans-
lational modifications. BMC Genomics 16, 617.
Clausen, T. (2003). Na+-K+ pump regulation and skeletal muscle contractility.
Physiol. Rev. 83, 1269–1324.
Cox, J., and Mann, M. (2008). MaxQuant enables high peptide identification
rates, individualized p.p.b.-range mass accuracies and proteome-wide pro-
tein quantification. Nat. Biotechnol. 26, 1367–1372.
Djouder, N., Tuerk, R.D., Suter, M., Salvioni, P., Thali, R.F., Scholz, R.,
Vaahtomeri, K., Auchli, Y., Rechsteiner, H., Brunisholz, R.A., et al. (2010).
PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis.
EMBO J. 29, 469–481.
Ducommun, S., Deak, M., Sumpton, D., Ford, R.J., Nu´n˜ez Galindo, A.,
Kussmann, M., Viollet, B., Steinberg, G.R., Foretz, M., Dayon, L., et al.
(2015). Motif affinity and mass spectrometry proteomic approach for the dis-
covery of cellular AMPK targets: identification of mitochondrial fission factor
as a new AMPK substrate. Cell. Signal. 27, 978–988.etabolism 22, 922–935, November 3, 2015 ª2015 Elsevier Inc. 933
Dzamko, N., Schertzer, J.D., Ryall, J.G., Steel, R., Macaulay, S.L., Wee, S.,
Chen, Z.P., Michell, B.J., Oakhill, J.S., Watt, M.J., et al. (2008). AMPK-inde-
pendent pathways regulate skeletal muscle fatty acid oxidation. J. Physiol.
586, 5819–5831.
Egan, B., and Zierath, J.R. (2013). Exercise metabolism and the molecular
regulation of skeletal muscle adaptation. Cell Metab. 17, 162–184.
Engholm-Keller, K., Birck, P., Størling, J., Pociot, F., Mandrup-Poulsen, T., and
Larsen, M.R. (2012). TiSH–a robust and sensitive global phosphoproteomics
strategy employing a combination of TiO2, SIMAC, and HILIC. J. Proteomics
75, 5749–5761.
Fentz, J., Kjobsted, R., Birk, J.B., Jordy, A.B., Jeppesen, J., Thorsen, K.,
Schjerling, P., Kiens, B., Jessen, N., Viollet, B., et al. (2015). AMPKalpha is crit-
ical for enhancing skeletal muscle fatty acid utilization during in vivo exercise in
mice. FASEB J. 29, 1725–1738.
Foretz, M., Guigas, B., Bertrand, L., Pollak, M., and Viollet, B. (2014).
Metformin: from mechanisms of action to therapies. Cell Metab. 20, 953–966.
Fullerton, M.D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen,
Z.P., O’Neill, H.M., Ford, R.J., Palanivel, R., O’Brien, M., et al. (2013). Single
phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the in-
sulin-sensitizing effects of metformin. Nat. Med. 19, 1649–1654.
Geiger, T., Velic, A., Macek, B., Lundberg, E., Kampf, C., Nagaraj, N., Uhlen,
M., Cox, J., and Mann, M. (2013). Initial quantitative proteomic map of 28
mouse tissues using the SILAC mouse. Mol. Cell. Proteomics 12, 1709–1722.
Gillet, L.C., Navarro, P., Tate, S., Rost, H., Selevsek, N., Reiter, L., Bonner, R.,
and Aebersold, R. (2012). Targeted data extraction of the MS/MS spectra
generated by data-independent acquisition: a new concept for consistent
and accurate proteome analysis. Mol. Cell. Proteomics 11, O111 016717.
Greenwald, E.C., Redden, J.M., Dodge-Kafka, K.L., and Saucerman, J.J.
(2014). Scaffold state switching amplifies, accelerates, and insulates protein
kinase C signaling. J. Biol. Chem. 289, 2353–2360.
Gwinn, D.M., Shackelford, D.B., Egan, D.F., Mihaylova, M.M., Mery, A.,
Vasquez, D.S., Turk, B.E., and Shaw, R.J. (2008). AMPK phosphorylation of
raptor mediates a metabolic checkpoint. Mol. Cell 30, 214–226.
Hardie, D.G. (2014). AMPK—sensing energy while talking to other signaling
pathways. Cell Metab. 20, 939–952.
Hawley, J.A., Hargreaves, M., Joyner, M.J., and Zierath, J.R. (2014).
Integrative biology of exercise. Cell 159, 738–749.
Højlund, K., Bowen, B.P., Hwang, H., Flynn, C.R., Madireddy, L., Geetha, T.,
Langlais, P., Meyer, C., Mandarino, L.J., and Yi, Z. (2009). In vivo phosphopro-
teome of human skeletal muscle revealed by phosphopeptide enrichment and
HPLC-ESI-MS/MS. J. Proteome Res. 8, 4954–4965.
Hornbeck, P.V., Kornhauser, J.M., Tkachev, S., Zhang, B., Skrzypek, E.,
Murray, B., Latham, V., and Sullivan, M. (2012). PhosphoSitePlus: a compre-
hensive resource for investigating the structure and function of experimentally
determined post-translational modifications in man and mouse. Nucleic Acids
Res. 40, D261–D270.
Humphrey, S.J., Yang, G., Yang, P., Fazakerley, D.J., Sto¨ckli, J., Yang, J.Y.,
and James, D.E. (2013). Dynamic adipocyte phosphoproteome reveals that
Akt directly regulates mTORC2. Cell Metab. 17, 1009–1020.
Jeppesen, J., Maarbjerg, S.J., Jordy, A.B., Fritzen, A.M., Pehmøller, C., Sylow,
L., Serup, A.K., Jessen, N., Thorsen, K., Prats, C., et al. (2013). LKB1 regulates
lipid oxidation during exercise independently of AMPK. Diabetes 62, 1490–
1499.
Klaus, A., Polge, C., Zorman, S., Auchli, Y., Brunisholz, R., and Schlattner, U.
(2012). A two-dimensional screen for AMPKsubstrates identifies tumor suppres-
sor fumarate hydratase as a preferential AMPKa2 substrate. J. Proteomics 75,
3304–3313.
Knight, J.D., Tian, R., Lee, R.E., Wang, F., Beauvais, A., Zou, H., Megeney,
L.A., Gingras, A.C., Pawson, T., Figeys, D., and Kothary, R. (2012). A novel
whole-cell lysate kinase assay identifies substrates of the p38 MAPK in differ-
entiating myoblasts. Skelet. Muscle 2, 5.
Linding, R., Jensen, L.J., Pasculescu, A., Olhovsky, M., Colwill, K., Bork, P.,
Yaffe, M.B., and Pawson, T. (2008). NetworKIN: a resource for exploring
cellular phosphorylation networks. Nucleic Acids Res. 36, D695–D699.934 Cell Metabolism 22, 922–935, November 3, 2015 ª2015 ElsevierLivigni, A., Scorziello, A., Agnese, S., Adornetto, A., Carlucci, A., Garbi, C.,
Castaldo, I., Annunziato, L., Avvedimento, E.V., and Feliciello, A. (2006).
Mitochondrial AKAP121 links cAMP and src signaling to oxidative metabolism.
Mol. Biol. Cell 17, 263–271.
Lundby, A., Secher, A., Lage, K., Nordsborg, N.B., Dmytriyev, A., Lundby, C.,
and Olsen, J.V. (2012). Quantitative maps of protein phosphorylation sites
across 14 different rat organs and tissues. Nat. Commun. 3, 876.
Maarbjerg, S.J., Jørgensen, S.B., Rose, A.J., Jeppesen, J., Jensen, T.E.,
Treebak, J.T., Birk, J.B., Schjerling, P., Wojtaszewski, J.F., and Richter, E.A.
(2009). Genetic impairment of AMPKalpha2 signaling does not reduce muscle
glucose uptake during treadmill exercise in mice. Am. J. Physiol. Endocrinol.
Metab. 297, E924–E934.
MacLean, B., Tomazela, D.M., Shulman, N., Chambers, M., Finney, G.L.,
Frewen, B., Kern, R., Tabb, D.L., Liebler, D.C., and MacCoss, M.J. (2010).
Skyline: an open source document editor for creating and analyzing targeted
proteomics experiments. Bioinformatics 26, 966–968.
Marrades, M.P., Gonza´lez-Muniesa, P., Martı´nez, J.A., and Moreno-Aliaga,
M.J. (2010). A dysregulation in CES1, APOE and other lipidmetabolism-related
genes is associated to cardiovascular risk factors linked to obesity. Obes.
Facts 3, 312–318.
Merrill, R.A., and Strack, S. (2014). Mitochondria: a kinase anchoring protein 1,
a signaling platform for mitochondrial form and function. Int. J. Biochem. Cell
Biol. 48, 92–96.
Neufer, P.D., Bamman, M.M., Muoio, D.M., Bouchard, C., Cooper, D.M.,
Goodpaster, B.H., Booth, F.W., Kohrt, W.M., Gerszten, R.E., Mattson, M.P.,
et al. (2015). Understanding the Cellular and Molecular Mechanisms of
Physical Activity-Induced Health Benefits. Cell Metab. 22, 4–11.
O’Neill, H.M., Maarbjerg, S.J., Crane, J.D., Jeppesen, J., Jørgensen, S.B.,
Schertzer, J.D., Shyroka, O., Kiens, B., van Denderen, B.J., Tarnopolsky,
M.A., et al. (2011). AMP-activated protein kinase (AMPK) beta1beta2 muscle
null mice reveal an essential role for AMPK in maintaining mitochondrial con-
tent and glucose uptake during exercise. Proc. Natl. Acad. Sci. USA 108,
16092–16097.
Reiter, L., Rinner, O., Picotti, P., Hu¨ttenhain, R., Beck, M., Brusniak, M.Y.,
Hengartner, M.O., and Aebersold, R. (2011). mProphet: automated data
processing and statistical validation for large-scale SRM experiments. Nat.
Methods 8, 430–435.
Rena, G., Pearson, E.R., and Sakamoto, K. (2013). Molecular mechanism of
action of metformin: old or new insights? Diabetologia 56, 1898–1906.
Richter, E.A., and Ruderman, N.B. (2009). AMPK and the biochemistry of ex-
ercise: implications for human health and disease. Biochem. J. 418, 261–275.
Ristow, M., Zarse, K., Oberbach, A., Klo¨ting, N., Birringer, M., Kiehntopf, M.,
Stumvoll, M., Kahn, C.R., and Blu¨her, M. (2009). Antioxidants prevent
health-promoting effects of physical exercise in humans. Proc. Natl. Acad.
Sci. USA 106, 8665–8670.
Sakamoto, K., and Goodyear, L.J. (2002). Invited review: intracellular signaling
in contracting skeletal muscle. J. Appl. Physiol. 93, 369–383.
Smyth, G.K. (2004). Linear models and empirical Bayes methods for assessing
differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol.
3, Article3.
Soboloff, J., Rothberg, B.S., Madesh, M., and Gill, D.L. (2012). STIM proteins:
dynamic calcium signal transducers. Nat. Rev. Mol. Cell Biol. 13, 549–565.
Steinberg, G.R., and Kemp, B.E. (2009). AMPK in Health and Disease. Physiol.
Rev. 89, 1025–1078.
Thorell, A., Hirshman, M.F., Nygren, J., Jorfeldt, L., Wojtaszewski, J.F.,
Dufresne, S.D., Horton, E.S., Ljungqvist, O., and Goodyear, L.J. (1999).
Exercise and insulin cause GLUT-4 translocation in human skeletal muscle.
Am. J. Physiol. 277, E733–E741.
Widegren, U., Jiang, X.J., Krook, A., Chibalin, A.V., Bjornholm, M., Tally, M.,
Roth, R.A., Henriksson, J., Wallberg-henriksson, H., and Zierath, J.R. (1998).
Divergent effects of exercise on metabolic and mitogenic signaling pathways
in human skeletal muscle. FASEB J. 12, 1379–1389.Inc.
Wojtaszewski, J.F., Nielsen, P., Kiens, B., and Richter, E.A. (2001). Regulation
of glycogen synthase kinase-3 in human skeletal muscle: effects of food intake
and bicycle exercise. Diabetes 50, 265–269.
Zhao, X., Leon, I.R., Bak, S., Mogensen, M., Wrzesinski, K., Hojlund, K., and
Jensen, O.N. (2011). Phosphoproteome analysis of functional mitochondria
isolated from resting humanmuscle reveals extensive phosphorylation of innerCell Mmembrane protein complexes and enzymes. Mol. Cell. Proteomics 10, M110
000299.
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M.,
Ventre, J., Doebber, T., Fujii, N., et al. (2001). Role of AMP-activated pro-
tein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167–
1174.etabolism 22, 922–935, November 3, 2015 ª2015 Elsevier Inc. 935
